Home/Filings/4/0001609351-19-000026
4//SEC Filing

Dalton Lisa 4

Accession 0001609351-19-000026

CIK 0001609351other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 5:16 PM ET

Size

13.4 KB

Accession

0001609351-19-000026

Insider Transaction Report

Form 4
Period: 2019-01-18
Dalton Lisa
Head of Human Resources
Transactions
  • Exercise/Conversion

    Common Stock

    2019-01-18+2,1623,547 total
  • Exercise/Conversion

    Common Stock

    2019-01-18+2,0004,755 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-01-182,1624,325 total
    Common Stock (2,162 underlying)
  • Tax Payment

    Common Stock

    2019-01-18$45.08/sh792$35,7032,755 total
  • Tax Payment

    Common Stock

    2019-01-18$45.08/sh621$27,9954,134 total
  • Exercise/Conversion

    Restricted Stock Units

    2019-01-182,0006,000 total
    Common Stock (2,000 underlying)
Footnotes (4)
  • [F1]Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutic's Inc. common stock.
  • [F3]On January 18, 2017, the reporting person was granted 7,000 restricted stock units that vest in four equal annual installments beginning January 18, 2018. Vested shares will be delivered to the reporting person annually on the vesting date.
  • [F4]On January 18, 2018, the reporting person was granted 8,000 restricted stock units that vest in four equal annual installments beginning January 18, 2019. Vested shares will be delivered to the reporting person annually on the vesting date.

Issuer

Spark Therapeutics, Inc.

CIK 0001609351

Entity typeother

Related Parties

1
  • filerCIK 0001732196

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:16 PM ET
Size
13.4 KB